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Supplement
The purpose of this supplement is to provide medical and health professionals with a review of
the health benefits of herbs and spices.
The University of Wollongong, partner organisation of the National Centre of Excellence in Functional Foods,
managed the development of the supplement through a committee comprising 
Professor Linda Tapsell, Dr Craig Patch and Ms Virginia Fazio.
Key academics and clinicians with expertise in health and nutrition were invited to review the health aspects 
of predominantly culinary herbs and spices, using scientific search strategies and 
National Health and Medical Research Council guidelines for assessing levels of evidence.
The resulting individual contributions were submitted to the management committee 
for the development of summary positions.
This supplement was supported by an educational grant from Gourmet Garden.
The views expressed in this supplement are those of the authors. Gourmet Garden had no influence on the content.
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Summary
Linda C Tapsell
Herbs and spices have a traditional history of use, with strong roles
in cultural heritage, and in the appreciation of food and its links to
health. Demonstrating the benefits of foods by scientific means
remains a challenge, particularly when compared with standards
applied for assessing pharmaceutical agents. Pharmaceuticals are
small-molecular-weight compounds consumed in a purified and
concentrated form. Food is eaten in combinations, in relatively
large, unmeasured quantities under highly socialised conditions.
The real challenge lies not in proving whether foods, such as herbs
and spices, have health benefits, but in defining what these
benefits are and developing the methods to expose them by
scientific means.
Cultural aspects
The place of herbs and spices in the diet needs to be considered in
reviewing health benefits. This includes definitions of the food
category and the way in which benefits might be viewed, and
therefore researched. Research may focus on identifying bioactive
substances in herbs and spices, or on their properties as a whole
food, and/or be set in the context of a dietary cuisine.
The role of herbs and spices in health
The antioxidant properties of herbs and spices are of particular
interest in view of the impact of oxidative modification of low-
density lipoprotein cholesterol in the development of atherosclero-
sis. There is level III-3 evidence (National Health and Medical
Research Council [NHMRC] levels of evidence1) that consuming a
half to one clove of garlic (or equivalent) daily may have a
cholesterol-lowering effect of up to 9%. There is level III-1
evidence that 7.2 g of aged garlic extract has been associated with
anticlotting (in-vivo studies), as well as modest reductions in
blood pressure (an approximate 5.5% decrease in systolic blood
pressure).
A range of bioactive compounds in herbs and spices have been
studied for anticarcinogenic properties in animals, but the chal-
lenge lies in integrating this knowledge to ascertain whether any
effects can be observed in humans, and within defined cuisines.
Research on the effects of herbs and spices on mental health
should distinguish between cognitive decline associated with
ageing and the acute effects of psychological and cognitive func-
tion. There is level I and II evidence for the effect of some herbal
supplements on psychological and cognitive function.
There is very limited scientific evidence for the effects of herbs
and spices on type 2 diabetes mellitus, with the best evidence
being available for the effect of ginseng on glycaemia, albeit based
on four studies. More research is required, particularly examining
the effects of chronic consumption patterns.
With increasing interest in alternatives to non-steroidal anti-
inflammatory agents in the management of chronic inflammation,
research is emerging on the use of food extracts. There is level II
evidence for the use of ginger in ameliorating arthritic knee pain;
however, the improvement is modest and the efficacy of ginger
treatment is ranked below that of ibuprofen. More definitive
research is required.
Public health and dietary implications
Recommendations for intakes of food in the Australian guide to
healthy eating2 do not yet include suggested intakes of herbs and
spices. Future consideration should be given to including more
explicit recommendations about their place in a healthy diet.
In addition to delivering antioxidant and other properties, herbs
and spices can be used in recipes to partially or wholly replace less
desirable ingredients such as salt, sugar and added saturated fat in,
for example, marinades and dressings, stir-fry dishes, casseroles,
soups, curries and Mediterranean-style cooking. Vegetable dishes
and vegetarian options may be more appetising when prepared
with herbs and spices.
Future directions
As several metabolic diseases and age-related degenerative disor-
ders are closely associated with oxidative processes in the body, the
use of herbs and spices as a source of antioxidants to combat
oxidation warrants further attention. Immediate studies should
focus on validating the antioxidant capacity of herbs and spices
after harvest, as well as testing their effects on markers of
oxidation. This will work in parallel with clinical trials that are
aiming to establish antioxidants as mediators of disease prevention.
From a dietary perspective, the functionality of herbs and spices
will be exposed through consideration of their properties as foods.
As with most foods, the real benefits of including them in the diet
are likely to emerge with a better understanding of the attributes of
health that are best supported by food, and in methodological
developments addressing the evidence base for their effects.3,4
These developments are well underway through evidence-based
frameworks for substantiating health claims related to foods.5 At
present, recommendations are warranted to support the consump-
tion of foods rich in bioactive components,6 such as herbs and
spices. With time, we can expect to see a greater body of scientific
evidence supporting the benefits of herbs and spices in the overall
maintenance of health and protection from disease.
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Background
The historical and cultural use of 
herbs and spices 
Ian Hemphill and Lynne Cobiac
Generally, the leaf of a plant used in cooking may be referred to as
a culinary herb, and any other part of the plant, often dried, as a
spice. Spices can be the buds (cloves), bark (cinnamon), roots
(ginger), berries (peppercorns), aromatic seeds (cumin), and even
the stigma of a flower (saffron). Many of the aromatic seeds known
as spices are actually gathered from plants when they have finished
flowering. A familiar example would be coriander, with the leaves
being referred to as a herb, and the dried seeds as a spice. When
referring to the stem and roots of coriander, which are used in
cooking, and to onions, garlic and the bulb of fennel, these parts of
these plants tend to be classified along with herbs, as they are often
used fresh and applied in a similar way to cooking.
Herbs and spices have a long history of both culinary use and of
providing health benefits, as well as acting as preservatives.
Ancient Egyptian papyri from 1555 BCE record the use of corian-
der, fennel, juniper, cumin, garlic and thyme.7 It is reported that
the Sumerians were using thyme for its health properties as early as
5000 BCE, and the farmers of Mesopotamia were growing garlic as
early as 3000 BCE. An international trade in spices dates back to
4500–1900 BCE, mainly with Ethiopia. The ancient Egyptians
worshipped garlic, and garlic cloves were found in the tomb of
King Tutankhamen. Other Egyptians had wooden cloves of garlic
in their tombs to keep the future meals of the afterlife tasty,
wholesome and long-lasting.8 Dried mint leaves have been found
in Egyptian pyramids dating around 1000 BCE.9 The Egyptians
reportedly fed large amounts of radishes, onions and garlic to their
slaves, ostensibly to keep them healthy.7 Cardamom and cinnamon
(traded from Ethiopia) were also used extensively in ancient Egypt
as spices, but less so for medicinal purposes. The Assyrians in
Mesopotamia (a country now incorporated by modern day Iraq
and Iran) also developed knowledge around the health benefits of
herbs, and refer to juniper, saffron, and thyme around this time.7
In ancient Greece and Rome, herbs appear to have been used
more than spices. Hippocrates (460–377 BCE) had a repertoire of
300 remedies that included garlic, cinnamon and rosemary, all of
which were locally available.7 He reportedly used garlic to treat
uterine cancer. Mint was highly valued for its positive effects on the
digestive system, and liquorice was used as a sweet, but also as a
herb for its anti-inflammatory actions and for asthma, chest
problems and mouth ulcers. Rosemary was used to improve and
strengthen memory — and is sometimes still burnt in the homes of
Greek students taking exams. Around the first century CE, Pedan-
ius Dioscorides — Greek physician, botanist, pharmacologist and
surgeon — published the first plant monograph that included 600
herbs, describing how to choose, store and apply plants for a range
of health benefits. Another Greek physician, Galen (131–200 CE),
who lived in Rome from 162 CE, had a strong influence on the
development of herbal remedies, but used complicated mixtures,
containing up to 100 ingredients.7 Dioscorides’ monograph was
used as a principal reference in Europe until the 17th century.9
In China, the use of plants for health benefits is shrouded in
legend. Two legendary Chinese emperors are credited with discov-
ering and recording the medicinal properties of herbs — Sheng
Nong, the Divine Husbandman (2838–2698 BCE), and Huang Di,
the Yellow Emperor (2698–2598 BCE).7 Traditionally, the Chinese
have integrated food, nutrition and health, and will often include
herbs and spices in specially prepared soups, dishes or beverages
for both sustenance and for purported health benefits. Ginseng
and Ginkgo biloba are reportedly used to improve stamina and
cognitive performance, respectively. Other examples include the
use of galangal for abdominal pain, nutmeg for diarrhoea, and
cinnamon for colds and flu.7
In India, the traditional medicine, Ayurveda, evolved more than
5000 years ago in the Himalayas, with knowledge transmitted orally
until it was written down in Sanskrit poetry — the Vedas — around
1500 BCE. It flourished in the 7th century. Ayurveda focuses on
disease prevention and health promotion, with an emphasis on
diet.10,11 Examples of Ayurvedic use of herbs and spices for health
effects include turmeric for jaundice, basil to protect the heart, mace
for stomach infections, cinnamon to stimulate circulation, and
ginger as the universal medicine, in particular for relieving nausea
and indigestion. Many of these herbs and spices are used in Indian
cooking to impart flavour, and significant quantities can be con-
sumed in one meal. It has been reported that such herbs and spices
can supply reasonable quantities of nutrients as well, such as iron. It
has been estimated that an adult in India can eat as much as 4 g of
turmeric daily, which could provide 80–200 mg/day of the bioactive
component curcumin. Some Indians have been reported to eat as
much as 50 g of garlic in a week.12
With the decline of the Roman Empire around 476 CE, the
development of Arabic medicine in 500–1300 CE preserved some
of the knowledge surrounding the health benefits of herbs and
spices, and built on the knowledge of Galen.7 The spread of
Islamic culture into north Africa had profound effects in the
region, blending their knowledge with that from China and India.
In the 9th century, the Emperor Charlemagne is quoted as
saying, “a herb is a friend of physicians and the praise of cooks”,
suggesting that the dual role of herbs and spices for flavouring and
for health benefits was still recognised. During the 11th century,
the knowledge of Arabic medicine filtered back to Europe, and by
the 13th century, trade with Africa and Asia was bringing in new
herbs and spices. Around this time, galangal was called the “spice
of life”.7 Garlic was used by herbalists during the plague.7 Later,
Louis Pasteur (1822–1895 CE) found that it killed bacteria, and it
was even used on the battlefields to prevent gangrene.
Mediterranean diets have been associated with reduced incidence of
some chronic diseases, such as heart disease and cancer.13 While
dietary studies are complex, Mediterranean diets do include consider-
able amounts of garlic, rosemary, basil and thyme, among other herbs,
which may help to explain some of the protective effects observed in
populations following more traditional Mediterranean diets.
In Australia, the Indigenous population developed its own local
herbal medicine based on the plants that were available. Their
isolation meant that the Indigenous population did not encounter
Western diseases, and so the use of herbs and plants was
developed for less serious disorders. Examples include the use of
river mint for coughs and colds, and wattle and eucalyptus for
diarrhoea, fever, headache, and a range of other ailments.14
Given the long history of use of herbs and spices, they may be
considered one of the first ever recorded functional foods.
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Herbs and spices as functional foods
Linda C Tapsell
Examining herbs and spices from a functional food perspective
might begin with how herbs and spices are used in the diet. There
is no single definition of functional foods, but there are many
contexts in which the concept is played out, including scientific
endeavour, technological advancement, food marketing, and food
standards regulation.15 From a scientific perspective, functional
foods have been defined as “foods that provide benefit beyond
basic nutrition”.16 This definition draws on notions of food (ie, a
recognisable unit of consumption in contradistinction to drugs),
notions of benefits (which implies the need for scientific evidence),
and the notion of “basic nutrition” (a concept open to interpreta-
tion). In some ways, basic nutrition might actually reflect the
current depth of nutrition knowledge and practice. Thus, meeting
requirements for vitamins and minerals (which have recom-
mended reference values)17 could be considered basic nutrition.
The underlying view is that these nutrients are required to
maintain normal bodily function. However, the way in which food
components of today are studied is not limited to concepts of
preventing clinical deficiency and maintaining homeostasis, but
includes a growing recognition of the way in which food compo-
nents actively interact with the body to support health and prevent
abnormality and overt disease.18
Herbs and spices fit into this picture in a number of ways. In this
supplement, the focus is on their role in the diet rather than their
use as medicines. Establishing this role would involve identifying
unique bioactive compounds to help identify target benefits.
Research would then be conducted on the food itself (supple-
ments), a meal based on the food (acute effects), or the food in a
whole diet in which the observed benefits can be attributed to the
specified combination. The traditional use of foods in various
cultures provides many clues to this development. For example,
certain meals in traditional Thai cuisine have a cultural history of
supporting health based on their combination of herbs, spices and
other foods,19 so that it might be better for dietary guidelines to
reference dishes, rather than single foods as we do in Western
societies (which tend to focus on targeted nutrients being delivered
by core food groups). The real challenge then comes from defining
benefits and providing the scientific evidence for these benefits.
In this supplement, the evidence for the benefits of herbs and
spices is reviewed in the areas of cardiovascular and metabolic
health, healthy ageing and cancer, and mental health and cogni-
tion. Applying nutrition knowledge about herbs and spices in
public health guidelines and dietary practice is also considered.
The supplement outlines the many ways in which the functionality
of herbs and spices could be considered, providing direction for
future research and developing an appreciation of the potential
contributions of herbs and spices to health and wellbeing.
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The health benefits of herbs and spices:
how strong is the evidence?
Cardiovascular disease
Craig S Patch and David R Sullivan
Most evidence concerning the cardiovascular effects of culinary
herbs and spices relates to the possible impact of garlic and garlic
oil. Consumption of garlic or garlic oil has been associated with a
reduction in total cholesterol, low-density lipoprotein (LDL) cho-
lesterol, and triglyceride levels. Studies suggest that an intake of
between half and one garlic clove per day can reduce cholesterol by
9%.20,21 This finding is consistent with a more recent meta-analysis
of 13 placebo-controlled trials involving 781 patients taking garlic
supplements. The authors concluded that intake of 600–900 mg of
standardised garlic extract per day was associated with a modest
0.41 mmol/L decrease in serum cholesterol level.22 Although this
was verified in the most current and comprehensive review,23 the
authors highlighted that the six most rigorous trials showed a non-
significant trend (Box 1).24-29
It has been suggested that this variation of effect may reflect a
loss of active compounds during processing, or an inhibition in the
enzymatic release of the active compounds from garlic.25 Allicin
has been proposed as the primary active compound, although the
mechanism of action is still not well understood. Allicin is not
present in fresh garlic and is converted from the precursor alliin
within seconds of being crushed or chewed. Allicin is rapidly
absorbed in the small intestine and converted to allyl mercaptan
and allyl methyl sulfide soon after absorption.30 In addition,
factors related to food preparation, manufacturing, and in-vivo
metabolism affect the bioactivity of allicin and may explain some
of the heterogeneity of results found in these meta-analyses.21,22
With few exceptions, the more recent published trials have used
dietary supplemental forms of garlic, rather than garlic as a food.30
This has significant implications, as a study found that the allicin
yield of 24 commercial brands of garlic tablets averaged 14% of the
amount claimed on the label.21,31  Of the brands used in most of
the clinical trials since 1995, the active ingredient was found to be
only 2%–18% of that claimed on the label.32
A number of clinical trials have examined the effect of garlic on
cardiovascular risk factors other than lipoproteins and lipid levels.
Garlic extracts have been associated with anticlotting effects,33 as well
as modest reductions in blood pressure (about a 5.5% decrease in
systolic pressure).34 However, of the 33 published studies with data
on blood pressure, only four included patients with hypertension.6
Data on the effects of other herbs and spices are limited. In one
trial, participants with hypercholesterolaemia who consumed
140 mg of lemon grass (Cymbopogon citratus) oil daily experienced a
drop in cholesterol concentrations by up to 38 mg/dL, but this trial
had no control group.35 Spice components like ginger, capsaicin
and curcumin have been associated with a decrease in LDL
cholesterol and an increase in high-density lipoprotein cholesterol
levels, but these results have been limited to rat studies.36,37
The putative protective heart health benefits of antioxidants such
as flavonoids have been extensively studied. A longitudinal study of
805 elderly men found that daily flavonoid intake from fruit,
vegetables and tea of 25.9 ±14.5 mg (mean ± SD) was inversely
associated with heart disease mortality.38 Herbs and spices have an
important role in dietary flavonoid intake. Chamomile, liquorice,
onions, rosemary, sage and thyme have high flavonoid contents, but
there is little evidence apart from epidemiological studies to
support a direct cardiovascular health benefit from these herbs and
spices.
In recent years, a substantial body of evidence has indicated that
free radicals contribute to cardiovascular disease.39 Oxidative mod-
ification of LDL is hypothesised to play a key role during the
development of atherosclerosis. The use of antioxidants from
dietary sources, including herbs and spices, is a promising alterna-
tive to the use of antioxidant supplements. In general, herbs and
spices have high antioxidant concentrations that have the potential
to inhibit the oxidation of LDL.40,41 Like fruits and vegetables,
herbs and spices contain many different classes of antioxidants in
varying amounts. It has been shown that the intake of herbs can
contribute significantly to the total intake of plant antioxidants.42 A
study found that the total phenolic content of culinary herbs ranged
from 0.26 mg to 17.51 mg of gallic acid per gram fresh weight
(Box 2).43 These values were also found to be higher than
traditional medicinal herbs.25 At this stage, evidence of benefit from
any form of antioxidant intake is restricted to surrogate markers of
cardiovascular disease, such as oxidative damage, rather than
clinical outcomes.
Obesity-related insulin resistance has emerged as a potent risk
factor for cardiovascular disease. Dietary factors that affect satiety
and thermogenesis could play an important role in determining the
prevalence and severity of this problem. Herbs and spices may have
a role to play in this regard. More data are also required on
bioavailability, bioactivity, and efficacy of culinary herbs on out-
comes.
Summary
• There is level III-3 evidence that a half to one clove of garlic (or
equivalent) daily may have a cholesterol-lowering effect of up to
9%.
• There is level III-1 evidence that 7.2 g of aged garlic extract has
been associated with anticlotting (in-vivo studies), as well as
modest reductions in blood pressure (about a 5.5% decrease in
systolic pressure).
• More evidence is required to determine any cardiovascular
health effects attributable to herb and spice antioxidants.
Cancer
Michael Fenech
As yet, there are no data indicating that herbs and spices have an
anticarcinogenic effect in humans, but there are several in-vitro
studies and rodent in-vivo studies suggesting that certain herbs
and spices may have a chemopreventive effect against the early
initiating stages of cancer (Box 3).
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HEALTH BENEFITS OF HERBS AN D SPICES:  THE PAST,  TH E PRESENT, THE FUTURE
Herbs may act through several mechanisms to provide protec-
tion against cancer. Certain phytochemicals from herbs or herb
extracts have been shown to inhibit one or more of the stages of
the cancer process (ie, initiation, promotion, growth and meta-
stases).62-65 Inhibition of phase I (procarcinogen activation) and
induction of phase II (carcinogen deactivation) metabolic enzymes
by herbal products may account for some of the preventive effects
against the induction of gene or chromosomal mutations that may
initiate cancer.62,63 For example, diallyl sulfide, a compound in
garlic, is an efficient inhibitor of the phase I enzyme cytochrome
P450 (CYP)3 IIE1 and significantly increases a variety of phase II
enzymes, including glutathione S-transferase, quinone reductase
and uridine diphosphate-glucuronosyltransferase, which are
responsible for the detoxification of carcinogens.63
Herbs may also protect against oxidative stress and inflamma-
tion, both of which are risk factors for cancer initiation and
promotion as well as other pathological conditions.64-67 An imbal-
ance between the generation of reactive oxygen species (eg,
hydroxyl radical and superoxide radical anion) and cellular anti-
oxidant capacity leads to a state of oxidative stress. Herbs and
spices contain several natural water-soluble phenolic acids and
flavonoids, such as caffeic acid and quercetin, that can scavenge
reactive oxygen species, as well as containing lipid-soluble com-
pounds such as tocopherols, carotenoids and sterols that may
protect against the generation of genotoxic lipid peroxidation
products, such as trans-4-hydroxy-2-nonenal.
Pro-oxidant and pro-inflammatory stimuli induce the mitogen-
activated protein and nuclear factor κB inhibitory protein (IκB)
kinases that activate nuclear factor κB (NFκB), enabling its translo-
cation into the nucleus where it causes activation of cyclo-
oxygenase-2 (COX-2) expression, subsequent prostaglandin pro-
duction, and excessive stimulation of cell division that can lead to
growth of adenomas.64-67 The pro-inflammatory and pro-oxidant
effect on increased cell proliferation, combined with oxidative-
stress-induced chromosomal instability, increases risk for carcino-
genesis (Box 4). The number of herbs with potential anti-inflam-
matory activity is impressive. Natural anti-inflammatory
compounds found in herbs and spices (such as curcumin, gingerol
and capsaicin) appear to operate by inhibiting one or more of the
steps linking pro-inflammatory stimuli with COX activation, such
as the blocking by curcumin of NFκB translocation into the
nucleus. It has been shown recently that the natural anti-inflam-
matory compounds quercetin, curcumin and silymarin were as
effective as indomethacin (a non-steroidal anti-inflammatory drug)
in inhibiting aberrant crypt foci in the rat.44
Herbs and spices (or their fractions and constituents) with
known anticarcinogenic effects in animal models of cancer include
turmeric, basil, rosemary, mint and lemon grass, but there are no
published reports on potential chemopreventive effects against
cancer for other common spices such as thyme, coriander and dill.
Turmeric has been widely used as a spice and colouring agent in
foods. Recently, turmeric was found to have chemopreventive
effects against cancers of the skin, forestomach, liver and colon,
and oral cancer in mice.44-46
Oral treatment with basil-leaf extract significantly elevated the
activities of cytochrome P450, aryl hydrocarbon hydroxylase, and
glutathione S-transferase, all of which are important in the detoxi-
fication of carcinogens as well as mutagens. Moreover, basil-leaf
extract was effective in inhibiting carcinogen-induced early-stage
cancers in the skin and forestomach of mice.47,68 Orientin and
vicenin, two water-soluble flavonoids isolated from the leaves of
Indian holy basil (Ocimum sanctum), have shown significant
protection against radiation-induced lethality and chromosomal
aberrations in vivo.48
A methanol extract of the leaves of the plant Rosmarinus
officinalis L. (rosemary) and its constituent carnosol (a phenolic
diterpene) inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-
induced ornithine decarboxylase activity (a promoter of cell
division via polyamine synthesis), TPA-induced inflammation,
arachidonic acid-induced inflammation, TPA-induced hyperplasia,
and TPA-induced tumour promotion in mouse skin.49 Commer-
cially available ground rosemary powder was shown to inhibit in-
vivo binding of 7,12-dimethylbenz[a]anthracene (DMBA) metabo-
lites to mammary cell DNA in rats,50 suggesting that components
of rosemary may inhibit breast cancer. In fact, dietary rosemary
and carnosol were both shown to inhibit rat mammary carcinogen-
esis when DMBA was used as the carcinogen.51 Using the C57BL/
6J/Min/+ (Min/+) mouse, a model of colonic tumorigenesis, it was
found that dietary administration of 0.1% carnosol decreased
intestinal tumour multiplicity by 46%, potentially via its ability to
enhance E-cadherin-mediated adhesion and suppress β-catenin
tyrosine phosphorylation.69 Carnosol has been shown to inhibit
the invasion of highly metastatic mouse melanoma B 16/F10 cells
in vitro.52 Furthermore, it has been shown to have antioxidant
activity and suppresses nitric oxide production and iNOS gene
expression by inhibiting NFκB activation, which suggests possible
mechanisms for its anti-inflammatory and chemopreventive
action.53
Geraniol, an acyclic monoterpene alcohol found in lemon grass
(Cymbopogon citratus), was shown to inhibit growth and polyamine
biosynthesis in human colon cancer cells.54 Citral (3,7-dimethyl-
2 Total phenolic content of common herbs and spices43
Herb or spice Botanical name
Total phenolic 
content
(mg of gallic acid/
g fresh weight) 
(Mean ±SEM)
Basil (Sweet) Ocimum basilicum L. 2.23 ± 0.15
Coriander 
(Vietnamese)
Polygonum odoratum 3.09 ± 0.12
Chives Allium schoenoprasum 1.05 ± 0.05
Dill Anethum graveolens 3.12 ± 0.06
Marjoram 
(hard sweet)
Origanum x majoricum 11.65 ± 0.29
Oregano (Cuban) Plectranthus 
amboinicus
0.34 ± 0.00
Oregano 
(Mexican)
Poliomintha longiflora 17.51 ± 0.22
Parsley Petroselinum crispum 1.12 ± 0.01
Rosemary Rosmarinus officinalis L. 2.19 ± 0.15
Spearmint Mentha spicata 0.94 ± 0.15
Thyme (Lemon) Thymus x citriodorus 1.78 ± 0.03
Garlic Allium sativum L. 1.03 ± 0.10
SEM = standard error of the mean. ◆
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2,6-octadienal), isolated from the methanol extract of lemon grass,
was identified as a novel inducer of the phase-2 enzyme glutath-
ione S-transferase.55 Lemon grass extract reduced the number of
putatively preneoplastic lesions and the level of oxidative hepato-
cyte nuclear DNA injury, as assessed in terms of 8-hydroxydeoxy-
guanosine production in the liver of male Fischer 344 rats.56
Inhibitory effects of lemon grass extract on the formation of
azoxymethane-induced DNA adducts and aberrant crypt foci (a
preneoplastic lesion) were recently demonstrated in the rat
colon.57
Perillyl alcohol, a naturally occurring monoterpene found in
lavender, cherries and mint, caused a 22% reduction in tumour
incidence and a 58% reduction in tumour multiplicity in a mouse
lung tumour bioassay.58 Rats given spearmint water extract (2%
weight/volume) as the sole source of drinking fluid before, during,
and after 2-week treatment with a colon carcinogen derived from
cooked meat, showed significant reductions in colonic aberrant
crypt foci compared with rats given water only.59
As a culinary herb, parsley is regularly consumed and parsley-
leaf oil is also used extensively for garnishing and seasoning.
Myristicin, a major volatile aroma constituent of parsley, showed
high activity as an inducer of the phase 2 enzyme glutathione S-
transferase in the liver and small intestinal mucosa of strain A/J
albino mice,60,61,70 and a 65% inhibition of tumour multiplicity in
a rodent lung cancer model.70
The results of studies cited above indicate the potential for
herbs and spices in chemoprevention of cancer in vitro and in
rodent cancer models. However, there is as yet no reliable
evidence for beneficial effects in humans in vivo at customary
intake levels. There is clearly a need for placebo-controlled
clinical trials to determine safety and optimal dosage, bioavail-
ability and bioefficacy of herbs and spices and their components
as chemopreventive agents against the various stages of cancer
directly in humans.
Summary
• There is potential for herbs and spices in chemoprevention of
cancer in vitro and in rodent cancer models.
• There is as yet no reliable evidence for beneficial effects in
humans in vivo at customary intake levels.
Mental health and cognition
Steven Roodenrys
There is a very long history in traditional medicine of the use of
plants to influence psychological states and processes as well as
physical health. In particular, the traditional practices of Ayurvedic
medicine in India and Chinese medicine have included treatments
for psychological conditions such as anxiety, and preparations to
enhance cognitive processes such as memory and attention. Recent
decades have seen an increased use of herbal preparations for both
of these purposes in Western society despite relatively little
scientific research having been conducted to investigate their
efficacy.
The herbs that have received the most scientific attention in
regard to influencing psychological processes have been drawn
from the traditional medicines rather than the culinary herbs. A
search of MEDLINE and PsycINFO using the various herb names
(eg, basil, coriander) and the terms cognition, memory, attention,
dementia and anxiety found only one study of the effect of any of
these herbs on psychological processes — it investigated the
hypnotic and anxiolytic effects of lemon grass. In this placebo-
controlled, double-blind study, lemon grass was taken as a herbal
tea for 2 weeks; no effects were found.71
The use of herbal treatments for anxiety is probably the most
common example of a herbal influence on mental health. Passiflora
incarnata, or passionflower, is approved for use as a sedative by the
German Commission E (an expert committee commissioned by
the German Government in 1978 to evaluate herbal drugs and
preparations from medicinal plants). Valeriana officinalis, or vale-
rian, is probably one of the most widely available herbal treat-
ments, and has been shown to have sedative effects in humans. A
review of evidence for behavioural effects and possible chemical
pathways for their action concludes that compounds in valerian
interact with GABA systems (widespread systems affected by γ -
amino butyric acid) in the brain; however, despite identifying
flavonoids in passionflower as the likely agent, they do not appear
to act on GABA receptors.72
More recently, herbs drawn from traditional Chinese medicine,
such as Ginkgo biloba and ginseng, have been advocated for a
reputed beneficial effect on cognitive processes.73 There is level I
evidence to support the claim that ginkgo can ameliorate
cognitive decline in dementia1,74 and level II evidence that it can
improve some aspects of memory function in healthy adults.1,75
Further, an extract from ginkgo has been shown to affect cerebral
circulation, activity in the cholinergic system, and to have
antioxidant properties, all of which may contribute to effects on
cognitive function (Box 5).81 However, a population-based study
4 Effect of pro-inflammatory stimuli on chromosomal 
instability and increased cell proliferation which, in 
combination, increase the risk of carcinogenesis. 
 Denotes steps in this carcinogenic process that may be inhibited by 
certain constituents of herbs and spices. ◆
Increased 
oxidative stress
DNA oxidation
Breaks in chromosomes
Telomere shortening
Chromosomal
instability
Mitogen-activated 
protein kinases
Nuclear factor κB 
activation
Increased 
cyclo-oxygenase-2 
expression
Increased 
cell proliferation
Pro-inflammatory stimuli
Increased cancer risk
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failed to find an effect on the recall of
newly learned information after a short
delay and the efficiency of working
memory processes after a 30-day inter-
vention.75
Consuming herbs can be expected to
benefit cognitive function to the extent
that they benefit cerebral circulation.
For example, it has been shown that
people with hypertension perform
more poorly on a range of cognitive
tasks,82 and cardiovascular disease is
associated with impaired cognition.83
Dietary factors that promote cardiovas-
cular health will therefore also maintain
cognitive function, although the effect
of any single foodstuff is likely to be
small.
Perhaps more importantly, antioxi-
dant intake is related to cognitive func-
tion because it  protects against
neuronal degeneration. A review of
studies of the effects of antioxidants on
Alzheimer’s disease shows quite mixed
results; this is attributed to the fact
that most studies involve participants
who have already been diagnosed with
dementia, while epidemiological stud-
ies suggest that the most likely benefit
of antioxidants is in preventing
dementia.76 Some epidemiological
studies have shown a relationship
between plasma levels of antioxidants
and dementia and cognitive impair-
ment.84 At this point in time, the
evidence suggests that total antioxi-
dant intake may influence cognitive
decline with age through the neuro-
protective action of antioxidants.
Summary
• There is little evidence that culinary
herbs and spices directly influence cog-
nition.
• There is level I and II evidence for
the effect of some herbal supplements
on psychological and cognitive func-
tion.
• Total antioxidant intake (to which
herbs and spices contribute) may influ-
ence cognitive decline with age through
the neuroprotective action of antioxi-
dants.
• Randomised, placebo-controlled in-
tervention studies of the effects of culi-
nary herbs and herbal supplements are
required.5
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Type 2 diabetes mellitus
Jennifer B Keogh and Peter M Clifton
The biguanide drug metformin, a popular
first-line treatment for diabetes, was devel-
oped from French lilac (Galega officinalis). To
date, this is the only plant-derived treatment
for diabetes. At present, the best clinical
evidence available for culinary herbs and
spices in the treatment of diabetes is for
cinnamon, and that is not very convincing.
Early in-vitro studies of spices such as cinna-
mon, cloves, bay leaves and turmeric have
shown that they display insulin-enhancing
activity.85,86 Mechanistic studies suggest that
extracts of cinnamon increase in-vitro glu-
cose uptake and glycogen synthesis and
increase insulin-receptor phosphoryla-
tion.87-89 A recent study tested the hypothe-
sis that cinnamon would lead to improved
glucose tolerance in people with type 2
diabetes mellitus.89 Sixty men and women
were randomly assigned to one of six
groups. The first three groups were given 1,
3 or 6 g of cinnamon (Cinnamomum cassia
extract in capsules) or placebo (same
number of capsules). After 40 days, all three
doses of cinnamon improved fasting glucose
levels (by 18%–29%; P < 0.05).89 However,
20 days later, glucose levels were still lower
with the lowest dose only, so it is not clear if
any of the effects were due to the spice. In
addition, glycated haemoglobin (HbA1c) lev-
els were not measured. It is not clear from
this study whether less than 1 g of cinnamon
per day would also be beneficial, and this is
an important question given that an intake
of more than 1 g of cinnamon daily would
require supplementation. Triglyceride and
LDL cholesterol levels were also lowered by
cinnamon, and this again persisted 20 days
after cessation of the spice in the two lowest
doses, suggesting that a reduction in energy
and fat intake had occurred in this group,
and this would account for the effects on
glucose. A second, double-blind randomised
crossover study of 29 postmenopausal
women with type 2 diabetes published this
year showed that 1.5 g of cinnamon daily
had no effect on whole-body insulin sensi-
tivity or oral glucose tolerance, and lipid
levels were also unchanged. In conclusion,
the effect of cinnamon is still unproven.90
There are many examples of non-culinary
herbs that have been tested for their effects
on blood glucose, but many of the data are
very poor. The 10 most popular plant prepa-
rations prescribed by herbalists in Italy for
glucose control are gymnema, psyllium,
fenugreek, bilberry, garlic, Chinese ginseng,
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dandelion, burdock, prickly pear cactus and bitter melon.91
Although there is also some evidence for the clinical efficacy of
ginseng in managing diabetes, there are concerns about the
reproducibility of its effect based on batch, dose and time of taking
the herb.92 A 2004 study reported differences in glycaemic effect
according to the type of ginseng tested, suggesting that the
antihyperglycaemic effect of ginseng can be highly variable.93 A
randomised clinical trial in 2000 evaluated ginseng in 19 lean
people; 10 without, and 9 with diabetes (Box 6).94 They received
3 g of ginseng or placebo 40 minutes before, or with, 25 g of
glucose. Participants (both with and without diabetes) taking
ginseng 40 minutes before the glucose showed a significant
reduction in glucose level compared with those taking placebo
(P < 0.05). There were also reductions in the area under the
glycaemic curve for both those with and without diabetes mellitus.
In a further study, 10 people without diabetes received, in random
order on 12 occasions, 0, 3, 6 or 9 g of ginseng at 40, 80, or 120
minutes before 25 g of glucose. Ginseng reduced postprandial
glucose levels (P < 0.05), and 9 g had a slightly greater effect than
3 g.95
Only one study has reported the effect of ginseng ingestion on
HbA1c. A 1995 report investigated the effect of ginseng in people
newly diagnosed with type 2 diabetes mellitus.96 Over 8 weeks, 36
participants were randomly assigned to receive either ginseng
(100 mg or 200 mg) or placebo. Overall, ginseng reduced fasting
blood glucose levels and body weight, and the group taking
200 mg of ginseng also showed reduced HbA1c levels. These
results suggest that ginseng may have a delaying effect on gastric
emptying, although a sulfonylurea-like activity may also play a
part.96 In conclusion, evidence supporting the efficacy of non-
culinary herbal treatments is limited and, at present, the best
evidence for clinical efficacy is for ginseng.
Summary
• Studies of herbal treatments in diabetes are often very small,
and extrapolating the results to the general population of people
with diabetes is not appropriate.
• The best evidence for effect on glycaemia is for ginseng (four
studies, with one reasonable sized study showing a reduced HbA1c
level with 200 mg of ginseng).
• Longer, larger randomised trials with acceptable clinical end-
points are needed to clarify the chronic effects of these herbs.
Osteoarthritis and inflammatory response
Craig S Patch
The role that diet plays in minimising the negative effects of ageing
has been extensively investigated. Target health issues related to
the ageing process include the process of oxidation, the promotion
of bone health, memory retention and cognition. With respect to
culinary herbs and spices, the best evidence is associated with anti-
inflammatory effect, particularly in mediating osteoarthritic pain
reduction.
Therapy for osteoarthritis is directed at symptoms, as there is no
established disease-altering treatment. Currently, treatment
options are confined to pharmacological interventions such as
analgesia, anti-inflammatory and intra-articular regimens.98 How-
ever, the recent withdrawal of cyclo-oxygenase inhibitors has led
many consumers to herbal remedies such as ginger. What follows
is a review of the evidence for efficacy of ginger in treating
symptomatic osteoarthritis.
Ginger (family Zingiberaceae) is a mixture of over several
hundred known constituents, including gingerols, β-carotene,
capsaicin, caffeic acid, curcumin and salicylate.99 Animal models
have been used for in-vitro and in-vivo testing of formulations and
powders of ginger, and have shown that it acts as a duel inhibitor
of both cyclo-oxygenase and lipo-oxygenase,100 as well as being an
inhibitor of leukotriene synthesis.101 Three trials have tested the
effects of ginger extract on pain. A randomised, placebo-controlled
crossover study of 46 patients with knee pain showed that ginger
had no effect. It was suggested that there may have been a carry-
over effect of the ginger extract which blurred the results, as
explorative statistics before the crossover suggested a positive
effect.102 However, in subsequent studies, ginger extract was found
to have a statistically significant effect in reducing knee pain, but
the effect was only moderate.103-105 An interesting recent trial of a
proprietary combination of iso-α-acids from hops, rosemary
extract and oleanolic acid (440 mg/day for 8 weeks) suggested a
beneficial effect on pain in patients with arthritis.106 Although
these findings seem promising, there is much more to be done in
this area. The relative effectiveness of different extracts is
unknown, and there are methodological limitations in measuring
this. More clinical studies are needed to confirm these results,
considering the confounding effects of the total diet.
A few studies, mostly randomised controlled trials, investigating
the effect of ginger on osteoarthritis and rheumatoid arthritis have
been identified (Box 7).102-104,107,109 Various doses of ginger
extract, ranging from 510 mg to 1 g per day, were tested. Pain level
was assessed by various validated measures of pain, such as visual
analogue scales, Western Ontario and McMaster Universities
(WOMAC) osteoarthritis index total score, and SF-12 Health
Survey. These trials found that the pain level of the participants in
the intervention group was significantly lower than that in the
placebo group, and suggests level II evidence1 for the efficacy of
ginger in this setting (P < 0.05). In addition, decreased use of non-
steroidal anti-inflammatory drugs and analgesics was also
observed. However, this improvement was modest103 and the
efficacy of ginger treatment was ranked below that of ibuprofen.102
Experimental studies have shown that ginger inhibits the
inflammation process. Ginger constituents are duel inhibitors of
arachidonic-acid metabolism (a key pathway in inflammation).110
Similar anti-inflammatory activity shown with turmeric (a member
of the ginger family) is also suggestive of a potential health
benefit.111 In addition, epidemiological studies have indicated that
populations that consume foods rich in specific polyphenols (such
as ginger) have lower incidences of inflammatory disease.112
Many questions remain to be answered about the effects of
antioxidants and the inflammatory process. Future intervention
studies should include a detailed assessment of the bioavailability
of antioxidants in addition to polyphenols. Beyond clinical trials
carried out with antioxidant-rich foods such as ginger, more
studies with pure, isolated compounds will also be needed to
establish their role in inflammatory diseases.
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Summary
• Various doses of ginger extract, ranging
from 510 mg to 1 g per day, reduce subjective
arthritic knee pain measures compared with
placebo (P < 0.05).
• Decreased use of non-steroidal anti-inflam-
matory drugs and analgesics has been observed
in study participants taking ginger extract.
• There is level II evidence for the use of
ginger in ameliorating arthritic knee pain; how-
ever, this improvement is modest, and the
efficacy of ginger treatment is ranked below
that of the ibuprofen prescribed to the partici-
pants.
7
Su
m
m
ar
y 
o
f 
e
vi
d
e
nc
e
 f
o
r 
he
al
th
 e
ff
ec
ts
 o
f 
he
rb
s 
an
d
 s
p
ic
es
 o
n 
ar
th
ri
ti
s
St
ud
y
D
es
ig
n
Pa
rt
ic
ip
an
ts
/o
rg
an
is
m
s/
 
ti
ss
ue
B
io
ac
ti
ve
 a
g
en
t/
so
ur
ce
D
o
se
M
ea
su
re
m
en
t
O
ut
co
m
e
W
ig
le
r 
et
 a
l1
04
6-
m
o
nt
h 
ra
nd
o
m
is
ed
, 
d
ou
b
le
-b
lin
d
, 
co
nt
ro
lle
d
, c
ro
ss
o
ve
r 
st
ud
y
29
 p
at
ie
nt
s 
w
ith
 
sy
m
p
to
m
at
ic
 g
o
na
rt
hr
iti
s
G
in
g
er
 e
xt
ra
ct
 v
 p
la
ce
b
o
1
g
/d
ay
 
(2
50
m
g
 c
ap
su
le
 
fo
ur
 t
im
es
 d
ai
ly
) 
Pa
in
 o
n 
m
o
ve
m
en
t 
an
d
 o
f h
an
d
ic
ap
 
(V
A
S 
o
f p
ai
n)
Si
g
ni
fic
an
tly
 lo
w
er
 p
ai
n 
le
ve
l w
as
 
fo
un
d
 in
 t
he
 g
in
g
er
 g
ro
up
. N
o 
si
g
ni
fic
an
t 
d
iff
er
en
ce
 w
as
 fo
un
d
 
b
et
w
ee
n 
g
ro
up
s 
at
 c
ro
ss
o
ve
r.
B
lid
d
al
 e
t 
al
10
2
Ra
nd
om
is
ed
, 
p
la
ce
b
o
-c
on
tr
ol
le
d
, 
cr
o
ss
o
ve
r 
st
ud
y
56
 p
ar
tic
ip
an
ts
w
ith
 
o
st
eo
ar
th
rit
is
C
hi
ne
se
 g
in
g
er
 e
xt
ra
ct
 
(E
V.
E
X
T3
3)
 c
ap
su
le
 
v 
ib
up
ro
fe
n 
v 
p
la
ce
b
o
17
0
m
g
 g
in
g
er
 e
xt
ra
ct
 
th
re
e 
tim
es
 d
ai
ly
;
40
0
m
g
 ib
up
ro
fe
n
d
ai
ly
Pa
in
 a
ss
es
sm
en
t 
(V
A
S 
of
 p
ai
n 
—
 
Fr
ie
d
m
an
 t
es
t)
E
ffi
ca
cy
 o
f t
re
at
m
en
t r
an
ke
d
 
ib
up
ro
fe
n 
ab
o
ve
 g
in
g
er
 a
nd
 
g
in
g
er
 a
b
o
ve
 p
la
ce
b
o
. N
o
 
si
g
ni
fic
an
t 
d
iff
er
en
ce
 w
as
 fo
un
d
 
b
et
w
ee
n 
ib
up
ro
fe
n 
an
d
 g
in
g
er
 
d
ur
in
g
 c
ro
ss
o
ve
r. 
A
ltm
an
 a
nd
 
M
ar
cu
ss
en
10
3
6-
w
ee
k 
ra
nd
o
m
is
ed
, 
d
ou
b
le
-b
lin
d
, p
la
ce
b
o
-
co
nt
ro
lle
d
, m
ul
ti
ce
nt
re
, 
p
ar
al
le
l-g
ro
up
 s
tu
d
y
24
7 
p
at
ie
nt
s 
w
ith
 
os
te
o
ar
th
rit
is
 o
f t
he
 k
ne
e 
an
d
m
o
d
er
at
e-
to
-s
ev
er
e 
p
ai
n
G
in
g
er
 e
xt
ra
ct
 (E
V.
EX
T7
7)
 
ca
p
su
le
25
5
m
g
tw
ic
e 
d
ai
ly
R
ed
uc
tio
n 
in
 “
kn
ee
 
p
ai
n 
on
 s
ta
nd
in
g
” 
(V
A
S 
o
f p
ai
n)
Si
g
ni
fic
an
t 
b
ut
 m
o
d
es
t 
im
p
ro
ve
m
en
t 
w
as
 fo
un
d
 in
 
th
e 
g
in
g
er
 e
xt
ra
ct
 g
ro
up
. 
So
ha
il 
et
 a
l1
07
8-
w
ee
k 
ra
nd
o
m
is
ed
, 
m
ul
tic
en
tr
e 
cl
in
ic
al
 tr
ia
l
65
 p
at
ie
nt
s 
w
ith
 
o
st
eo
ar
th
rit
is
 
an
d
 
rh
eu
m
at
o
id
 a
rt
hr
iti
s
St
in
g
in
g
 n
et
tle
 e
xt
ra
ct
D
ev
il’
s 
cl
aw
 e
xt
ra
ct
G
in
g
er
 ro
ot
 e
xt
ra
ct
(a
s 
at
ris
in
 c
ap
su
le
)
30
0
m
g
20
0
m
g
20
m
g
(a
ll 
tw
ic
e 
d
ai
ly
)
A
ss
es
sm
en
t 
o
f p
ai
n 
an
d
 fu
nc
tio
na
l 
d
is
ab
ili
ty
 
(V
A
S 
o
f p
ai
n)
Im
p
ro
ve
m
en
ts
 in
 a
ll 
ef
fic
ac
y 
p
ar
am
et
er
s 
w
er
e 
o
b
se
rv
ed
. 
Le
ss
 N
SA
ID
 a
nd
 a
na
lg
es
ic
 
m
ed
ic
at
io
ns
 w
er
e 
us
ed
 b
y 
p
ar
ti
ci
p
an
ts
.
M
uh
lb
au
er
 e
t 
al
10
8
In
-v
iv
o
 a
ni
m
al
 s
tu
d
y
11
 W
is
ta
r H
an
lb
m
 r
at
s
Po
w
d
er
ed
 s
ag
e,
 
ro
se
m
ar
y 
an
d
 t
hy
m
e
1
g
U
rin
ar
y 
ex
cr
et
io
n 
o
f [
3 H
]-
te
tr
ac
yc
lin
e
B
o
ne
 re
so
rp
tio
n 
w
as
 s
ig
ni
fic
an
tly
 
re
d
uc
ed
/i
nh
ib
ite
d
.
E
ss
en
tia
l o
il 
ex
tr
ac
te
d
 
fr
o
m
 s
ag
e 
an
d
 r
os
em
ar
y
Va
rio
us
U
rin
ar
y 
ex
cr
et
io
n 
o
f [
3 H
]-
te
tr
ac
yc
lin
e
Si
g
ni
fic
an
t 
in
hi
b
it
io
n 
o
f 
b
o
ne
 re
so
rp
tio
n.
In
-v
it
ro
 a
ni
m
al
 s
tu
d
y
O
st
eo
cl
as
ts
 fr
o
m
 
W
is
ta
r 
H
an
lb
m
 r
at
s
M
on
o
te
rp
en
es
 (b
o
rn
eo
l, 
th
ym
o
l a
nd
 c
am
p
ho
r)
1.
0
m
m
o
l/
L
B
on
e 
re
so
rp
ti
ve
 
ac
tiv
iti
es
D
ire
ct
 in
hi
b
iti
o
n 
o
f t
he
 
os
te
o
cl
as
t r
es
or
p
tio
n 
p
it 
as
sa
y.
EV
.E
X
T3
3 
an
d
 E
V.
EX
T7
7 
ar
e 
p
at
en
te
d
 s
ta
nd
ar
d
is
ed
 g
in
ge
r e
xt
ra
ct
s.
 V
A
S
=
vi
su
al
 a
na
lo
g
ue
 s
ca
le
. N
SA
ID
=
no
n-
st
er
o
id
al
 a
nt
i-i
nf
la
m
m
at
or
y 
d
ru
g
.
◆
MJA • Volume 185 Number 4 • 21 August 2006 S17
HEALTH BENEFITS OF HERBS AN D SPICES:  THE PAST,  TH E PRESENT, THE FUTURE
Public health
Peter G Williams
It is difficult to estimate the current level of consumption of
culinary herbs and spices by Australians. The Australian Bureau
of Statistics trend data on apparent consumption of foods do not
include herbs and spices,113 and results from the last National
Nutrition Survey (NNS) in 1995 provide only limited informa-
tion on consumption — that median daily intake of herbs,
spices, seasonings and stock cubes combined was estimated to be
1.4 g per adult (declining with age from 4.2 g in 19–24-year-olds,
to 0.7 g in those aged 65 years and older), with only 3.1% of
people reported consuming this category of food items on the
day of survey.114 The separate intakes of herbs and spices alone
are not reported. Intake by males appeared to be higher than that
by females, but the low values make it difficult to assess the
significance of this difference. In New Zealand, the consumption
of spices, estimated using import data, was 364 g per year, or
around 1g per day,115 a similar value to that reported in the NNS.
One comparison of spices used in representative vegetable-
based and meat-based recipes from 36 different countries found
Australia (with a mean of 3.4 spices per recipe) had a moderate
level of use compared with the international mean of 3.9
(ranging from 1.6 in Norway to 6.9 in Indonesia).116 However,
increased use of herbs and spices as flavourings in foods is a
major trend worldwide,117 with sales growth of 20%–30% over
the past 5 years in both the United Kingdom and the United
States.118 It has been suggested that this trend is partly driven by
demographics; as consumers age, their palates can become more
adventurous. Promotion can also be important — a recent UK
advertisement in which Jamie Oliver encouraged consumers to
experiment with nutmeg boosted sales of that spice fourfold.119
Based on retail sales data, consumption of herbs and spices in
Australia has increased in line with global trends, and this is
expected to continue. The market for local fresh-cut culinary
herbs was estimated to be worth over $62 million per year in
2004 and continues to grow at 20% per annum.105 Information
from major supermarket sales in 2003 suggests that total retail
sales of fresh herbs and spices were valued at $54 million, and
sales for dried products were valued at a further $107 million.
The sales volumes of fresh herbs are shown in Box 8.
Although there is increasing interest and research in the
health-promoting and protective properties of herbs and
spices,120-122 there are few authoritative recommendations about
intake in existing national dietary guidelines. The first recom-
mendation in the NHMRC dietary guidelines for Australian
adults is “Enjoy a wide variety of nutritious foods”,123 and in the
NHMRC dietary guidelines for older Australians, a food variety
checklist given in an appendix includes the recommendation to
use herbs and spices regularly.124 The same food variety checklist
has also been used as the basis of a checklist to assess intakes of
phytochemical-dense foods, and herbs and spices make up 11
out of the 64 foods in the checklist (basil, oregano, mint, dill/
fennel, parsley, pepper, ginger, cumin, turmeric, coriander, rose-
mary/thyme).125
The higher the score the more adequate the diet is suggested to
be in phytochemicals. However, it is acknowledged that such
food scores need to be further developed, and are not backed by
any health outcome studies at this stage.
The two NHMRC dietary guidelines each have another recom-
mendation for using herbs and spices. In the dietary guidelines
for adults, the background chapter on choosing foods low in salt
states that among the recommended substitutes for salt are
ingredients such as curry spices, garlic and onion, and herbs.123
The guidelines for older Australians note particularly that age-
related sensory loss of smell and taste is common in older people,
especially those who take many medications, and can have
adverse effects on overall nutrient intake. The guidelines recom-
mend experimentation with new flavourings such as herbs and
spices to stimulate appetite and support adequate overall
intakes.124
A few other countries have made similar recommendations
about herbs and spices. In the 2005 revision of the Dietary
guidelines for Americans, the chapter on choosing a diet moderate
in salt and sodium recommends flavouring with herbs and
spices.126 Perhaps the country with the most direct recommenda-
tion about the health benefits of culinary herbs is Greece. Their
dietary guidelines not only refer to the usefulness of herbs as salt
substitutes, but also state: “oregano, basil, thyme and other herbs
grown in Greece are good sources of antioxidant compounds”.127
This emphasis on the health-promoting properties of herbs is of
interest, given research in Australia that has found that first
generation Greek migrants have 35% lower mortality from
cardiovascular and overall mortality than Australian-born con-
trols, despite high prevalence of risk factors such as obesity,
smoking and sedentary lifestyles. It has been suggested that one
of the dietary factors contributing to this lower mortality could
be their high intake of antioxidant-rich plant foods, including
garlic and herbs.128
Despite the generally supportive statements in the dietary
guidelines, the quantitative recommendations for intakes of food
8 Major supermarket sales of fresh herbs and spices in 
Australia 2003105
Herb or spice Amount sold (kg) Retail sales value
Garlic 1 767 000 $7 941 100
Ginger 592 900 $7 259 900
Chilli 425 000 $3 755 300
Basil 74 200 $7 373 200
Coriander 73 900 $8 860 600
Parsley 30 500 $8 415 000
Mint 18 800 $2 151 500
Chives 18 400 $2 225 500
Lemon grass 17 400 $950 300
Rosemary 15 200 $1 169 700
Oregano 9 700 $594 700
Dill 6 100 $1 074 900
Thyme 3 600 $693 300
Other 845 800 $9 104 000
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in the Australian guide to healthy eating do not yet include
suggested intakes of herbs and spices.129 Those recommendations
aim primarily to ensure adequate intakes of nutrients for which
recommended dietary intakes have already been established, and
it is probably too early for there to be more definitive recommen-
dations about foods based on their content of other phytochemi-
cals. It should also be borne in mind that there are possible
adverse effects of some spices (such as chilli and peppers) if
consumed in large quantities,121 although this is unlikely to be a
significant risk at normal levels of use. Thus, the apparent
increasing consumption of culinary herbs and spices is certainly a
welcome trend that is worthy of closer monitoring, and in future,
more explicit recommendations about their place in a healthy diet
should be included.
Summary
• Recommendations for intakes of food in the Australian guide to
healthy eating do not yet include suggested intakes of herbs and
spices.
• Future consideration should be given to including more
explicit recommendations about the place of herbs and spices in a
healthy diet.
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Dietary implications
Virginia A Fazio and Karen E Inge
Food variety and diversity
The use of herbs and spices can assist in increasing the consump-
tion of vegetables and fruit. Many national nutrition guidelines
stress the importance of consuming a wide variety of food,
including the Australian guide to healthy eating,2 Eat well Australia130
and Dietary guidelines for Americans.126 The healthy nutrition
message is now one of increasing food variety and diversity to
maximise the range of nutrients consumed on a regular basis.
Internationally, there are programs such as the “Go for 2&5”
campaign in Australia131 and “5 a day the color way” in the US.132
Herbs and spices naturally fit within such programs, as they
encourage increased use of vegetables by adding flavour and
interest to the diet.
Campaigns throughout the world encouraging an increase in the
consumption of fruits and vegetables are consistent with the
dietary guidelines promoted by the World Health Organization.133
There are multiple factors that influence the quantity and variety of
vegetables consumed. Research from the US suggests that factors
such as age, education, and percentage of income spent on food at
home are all positive influences on the amount and variety of
vegetables consumed. This research also shows that the number of
children in large households reduces the variety of vegetables
consumed.134 In addition, an analysis by the Australian Institute of
Health and Welfare of the 2001 National Health Survey found that
the percentage of people who consumed fewer than four serves of
vegetables a day decreased with age. In addition, 76.8% of those
aged 19–34 years were low vegetable consumers, as were 62.4% of
those aged 75 years and over.135 One of the barriers to increasing
consumption is the limited range of preparation techniques
(including interesting flavours) that people feel confident in using
with fruit and vegetables.135
Herbs and spices increase bioavailability of 
other nutrients
The nutrients and other biologically active components (such as
antioxidants) in food do not always show the same health benefits
when the active substance is isolated from food and ingested as a
pure compound.136 There are synergistic effects between nutrients
that affect absorption and bioavailability.136 Salad dressings con-
taining herbs and spices can increase the antioxidant capacity of
the salad.137 Marjoram, for example, has been shown to increase
the antioxidant capacity by 200%137 (ie, a 200 g portion of a salad
enriched with 3 g of marjoram equated to an intake of 4000
oxygen radical absorbance capacity units).137 On the other hand,
the presence of herbs and spices will not always result in improved
absorption of nutrients. Just as some vegetables can limit the
absorption of calcium, zinc and iron, research has shown, for
example, that a reduction in non-haem iron absorption can be
seen in the presence of rosemary oil.138
Practical application
The use of herbs and spices may help to lower salt, fat and sugar
intake. Some practical advice includes:
• Stir fries can have meat or chicken or fish marinated before
cooking in minimal oil. These dishes often include the addition of
garlic, ginger and chilli.
• Curries can be based on either meat or vegetables. Low-fat
curries rely on minimal use of coconut milk or cream, but many
traditional curries and their accompaniments are low in fat. Herbs
and spices are integral to the seasoning of these dishes.
• There is an enormous variety of Mediterranean dishes. Many of
the recipes have high proportions of vegetables and rice, pasta or
couscous. The oils used are generally heart-friendly.
• Fresh herbs are usually better added towards the end of
cooking or just before serving to preserve their flavour. Parsley can
be added at any time.
• Amounts of fresh herbs used are usually 2–4 times more than
dried herbs. Some herbs like basil darken when bruised but this
does not change the flavour. All fresh herbs should be prepared
just before using.
• Dried herbs can be added at any stage of cooking, but use
should be guided by recipes as some herbs, such as bay leaves, are
added very early in cooking. Some dried spices are heated at the
beginning of cooking to release their flavours. More flavour is
released by grinding with a mortar and pestle.
• Garlic releases more flavour when it has been chopped or
mashed. It should not be overheated as it may burn and become
bitter.
• The hottest parts of chillies are the seeds and white internal
membranes. Removing them will result in a milder flavour.
Understanding food combinations is important in cooking with
herbs and spices. Traditional use matches them with certain foods,
but this is not meant to be restrictive. Herbs are clustered into
families, so the traditional combinations can be exchanged with
others from the same family for variety or personal taste prefer-
ences.
Parsley family
• Parsley — in multiple forms, used raw and in cooking with
meat, fish, chicken and vegetables.
• Dill — used in salads, sauces and with fish, sour cream, and in
cheese and potato dishes.
• Coriander (cilantro) — popular in Mexican cooking and many
Asian and Middle Eastern cuisines. Useful in marinades, dressings,
salsas and in cooked dishes. Leaves, roots and seeds are used.
Mint family
• Mint — many forms with slightly different tastes are used raw
and in cooking, dressings, marinades, drinks, yoghurt, desserts,
sauces, vegetable dishes and salads.
• Basil — used with tomatoes (fresh and in sauces) and in soups 
and casseroles with tomato. Also used in salad dressings, pesto,
and with pasta, rice, vegetables, meat, chicken and seafood, and in
South-East Asian cooking in curries, soups and noodle dishes.
• Marjoram — used in meat, fish, egg, and cheese dishes, and in
pizza.
• Oregano — essential for Italian and Greek dishes, but also used
in cheese and egg dishes.
• Sage — used with veal, and in stuffing and cheese dishes.
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• Thyme — used in casseroles, soups, and poultry stuffing.
• Rosemary — used in marinades, sauces and stuffing, and with
fish, poultry and soups.
Allium family
• Chives — used in salad dressings, soups, light sauces, and with
egg, cheese, fish and chicken.
• Garlic — included in almost every cuisine from Asian to
Mediterranean. Used in marinades, dressings, sauces, and in stir-
fried and slow-cooked dishes.
Other
• Bayleaves — generally used in slow-cooked meat and soup
dishes.
• Chilli — used with meat, chicken and poultry, shellfish, tomato
dishes, and curries. Popular in Asian, Mexican, African and
Caribbean cooking.
• Ginger — used in many Asian dishes, but also in cakes,
biscuits, desserts and with fruit and juices.
• Lemon grass — can be used as a tea or beverage and is included
in many Asian dishes.
• Tarragon — used with chicken and fish and in salad dressings
and egg dishes.
Summary
• The use of herbs and spices may encourage variety in food
intake. Herbs and spices support nutrient diversity by encouraging
new food choices.
• Higher vegetable intakes are linked with improved health.
Vegetarian options and vegetable dishes may be more appetising
when prepared with herbs and spices.
• Many low-fat cooking methods are improved by using herbs
and spices in soups, casseroles, marinades and dressings.
• Herbs and spices are a healthy alternative to salt as a seasoning.
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Moving forward
Linda C Tapsell
Herbs and spices have only recently captured the attention of the
scientific community as providing potential health benefits. As a
result, there needs to be a significant investment in human clinical
trials to substantiate many of the hypothesised health benefits.
Nevertheless, this review provides encouragement for further
scientific inquiry. The evidence presented in this review suggests
that most of the health effects of herbs and spices on cancer,
cardiovascular disease, arthritis and mental health protection may
be mediated through their potent antioxidant effects, given the
range of activity across the group as a whole (Box 9).42 As science
uncovers the role of antioxidants in many degenerative diseases
associated with ageing, herbs and spices may have a place as an
important source of antioxidants in the diet.
While the bioactivity of individual antioxidants may be known,
their effects on health may not be as significant as the combination
of the whole class of bioactives working through multiple mecha-
nisms of action. This may well be the case in nutrition generally,
where, for example, it is now being argued that the health benefits
of n-3 fatty acids are attributed to moderate health effects mediated
through multiple pathways rather than a single significant mecha-
nism.139 Like the work undertaken with these essential fatty acids,
research is required to uncover the mechanisms by which antioxi-
dants deliver health benefits, and then the impact of exogenous
antioxidants in this context. A deeper understanding of this role
will help to establish recommended intakes, as has been the case for
vitamins and minerals. Finally, an understanding of how antioxi-
dant-rich foods (such as herbs and spices) fit within the context of
the whole diet, in balance with all other requirements, will enable
research at the clinical level to establish the evidence for their
putative place in health promotion and disease prevention.
In summary, as several metabolic diseases and ageing-related
degenerative disorders are closely associated with oxidative pro-
cesses in the body, the use of herbs and spices as a source of
antioxidants to combat oxidation warrants further attention.
Immediate studies should focus on validating the antioxidant
capacity of herbs and spices after harvest, as well as testing their
effects on markers of oxidation. This will work in parallel with
clinical trials that are aiming to establish antioxidants as mediators
of disease prevention.
9 Antioxidant activity of common dried herbs and 
spices.42
Common name Botanical name
Antioxidant
activity*
Clove Syzygium aromaticum 465.3 mmol/100 g
Oregano Origanum vulgare 137.5 mmol/100 g
Cinnamon Cinnamomum zeylanicum 98.4 mmol/100 g
Peppermint Mentha piperita 78.5 mmol/100 g
Thyme Thymus vulgaris L. 74.6 mmol/100 g
Rosemary Rosmarinus officinalis L. 66.9 mmol/100 g
Marjoram (sweet) Origanum majorana 55.8 mmol/100 g
Basil Ocimum basilicum L. 30.9 mmol/100 g
Ginger Zingiber officinale 22.5 mmol/100 g
Dill Anethum graveolens 15.9 mmol/100 g
Curry Murraya koenigii L. 13.0 mmol/100 g
Chives Allium schoenoprasum 7.1 mmol/100 g
Parsley Petroselinum crispum 3.6 mmol/100 g
Coriander Coriandrum sativum L. 3.3 mmol/100 g
Vanilla seeds Vanilla planifolia 2.6 mmol/100 g
Garlic Allium sativum L. 2.1 mmol/100 g
* Mean total antioxidant activity per 100 g. ◆
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